PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.74 -1.17 (-5.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Short term Debt (2020)

PROCEPT BioRobotics (PRCT) posted quarterly Short term Debt of $4.6 million for Q4 2020.

PROCEPT BioRobotics (PRCT) Short term Debt (2020) Analysis & Trends

PROCEPT BioRobotics (PRCT) has reported Short term Debt for 1 consecutive years, with $4.6 million the latest figure, recorded in Q4 2020.

  • In Q4 2020, Short term Debt changed N/A year-over-year to $4.6 million; the TTM figure through Dec 2020 stood at $4.6 million (changed N/A YoY), while the FY2020 annual figure was $4.6 million, changed N/A from the prior year.
  • Short term Debt held at $4.6 million in Q4 2020 per PRCT's latest filing.
  • Across five years, Short term Debt topped out at $4.6 million in Q4 2020 and bottomed at $4.6 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 PROCEPT BioRobotics 1.19 Bn 911.91 Mn 62.38 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 4.55 Mn